Dermapharm Holding SE: Annual General Meeting Resolves Dividend Distribution of EUR 0.88 Per Share

Dermapharm Holding SE held its Annual General Meeting for 2024 on June 27. The company approved a dividend distribution of EUR 0.88 per share, amounting to a total distribution of EUR 47.4 million. This represents approximately 78% of the distributable consolidated net income. The meeting saw strong approval for the Board of Management's actions, with 98.6% and 91.5% majority of votes ratifying the actions of the Board of Management and Supervisory Board, respectively.

Dermapharm confirmed its outlook for 2024, expecting consolidated revenue between EUR 1,170–1,210 million and adjusted consolidated EBITDA of EUR 305–315 million. The meeting also re-elected Grant Thornton AG as the auditor for the financial year, and RSM Ebner Stolz GmbH & Co. KG for the sustainability reporting.

CEO Dr. Hans-Georg Feldmeier highlighted the company's strategic investments, including the acquisition of Arkopharma and Montavit, and steps toward energy efficiency. Despite a challenging macroeconomic environment, Dermapharm maintained its growth curve and continues to focus on international expansion.